Top compounds associated with response to RP11-146B14.1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA MST-312 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.003
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.098 0.004
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.12 0.004
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.11 0.004
mRNA ELCPK CTRPv2 pan-cancer AAC 0.16 0.004
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.1 0.004
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.11 0.005
mRNA etoposide CTRPv2 pan-cancer AAC 0.09 0.005
Download CSV